Masupirdine (SUVN‐502) in combination with donepezil and memantine in moderate Alzheimer's disease: Effect of AD duration since diagnosis and patient’s age on efficacy endpoints
| Autor: | Mohammed Abdul Rasheed, Ramkumar Subramanian, Ramakrishna Nirogi, Shinde Anil Karbhari, Venkat Jasti, Jyothsna Ravulu, Vijay Benade, Gopinadh Bhyrapuneni, Satish Jetta, Rajesh Kumar Badange |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Epidemiology business.industry Health Policy Memantine Cognition Disease Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Internal medicine Medicine Neurology (clinical) Geriatrics and Gerontology Duration (project management) business Donepezil medicine.drug |
| Zdroj: | Alzheimer's & Dementia. 16 |
| ISSN: | 1552-5279 1552-5260 |
| DOI: | 10.1002/alz.039283 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|